Soleno Therapeutics, Inc.

SLNO

$47.25

Name : Soleno Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $2,537,798,656.00

EPSttm : -1.75

Soleno Therapeutics, Inc.

$47.25

4.39%

$2.17

Float Short %

17.91

Margin Of Safety %

Put/Call OI Ratio

0.47

EPS Next Q Diff

0.13

EPS Last/This Y

4.56

EPS This/Next Y

3.45

Price

47.28

Target Price

116.75

Analyst Recom

1.08

Performance Q

-29.28

Relative Volume

1.14

Beta

-3.08

Ticker: SLNO

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	SLNO	65.45	0.52	0.35	79716
2025-10-21	SLNO	67.45	0.51	0.83	81769
2025-10-22	SLNO	66.84	0.51	0.23	82370
2025-10-23	SLNO	63.63	0.51	0.47	82401
2025-10-24	SLNO	64.12	0.52	0.13	82491
2025-10-27	SLNO	67.46	0.52	0.42	82948
2025-10-28	SLNO	68.71	0.52	0.20	84505
2025-10-29	SLNO	69.96	0.47	0.04	93870
2025-10-30	SLNO	69.23	0.47	0.16	93945
2025-10-31	SLNO	67.11	0.46	0.30	95754
2025-11-03	SLNO	65.66	0.47	0.94	95274
2025-11-04	SLNO	63.81	0.46	0.36	97720
2025-11-05	SLNO	46.87	0.46	0.33	104160
2025-11-06	SLNO	43.49	0.42	0.36	113070
2025-11-07	SLNO	47.75	0.44	1.19	111150
2025-11-10	SLNO	46.37	0.44	0.10	112175
2025-11-11	SLNO	48.3	0.44	1.63	112869
2025-11-12	SLNO	47.74	0.47	0.40	118235
2025-11-13	SLNO	47.73	0.47	1.41	122036
2025-11-14	SLNO	49.82	0.47	0.64	122936
2025-11-17	SLNO	47.26	0.47	0.74	123109
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	SLNO	65.45	-	-	-0.67
2025-10-21	SLNO	67.08	-	-	-0.67
2025-10-22	SLNO	66.90	-	-	-0.67
2025-10-23	SLNO	63.63	-	-	-0.67
2025-10-24	SLNO	64.15	-	-	-0.67
2025-10-27	SLNO	67.46	-	-	-0.67
2025-10-28	SLNO	68.66	-	-	-0.67
2025-10-29	SLNO	69.90	-	-	-0.67
2025-10-30	SLNO	69.28	-	-	-0.67
2025-10-31	SLNO	67.16	-	-	-0.67
2025-11-03	SLNO	65.63	-	-	-0.67
2025-11-04	SLNO	63.77	-	-	-0.67
2025-11-05	SLNO	46.99	-	-	-0.67
2025-11-06	SLNO	43.56	-	-	-0.67
2025-11-07	SLNO	47.70	-	-	-0.66
2025-11-10	SLNO	46.31	-	-	-0.66
2025-11-11	SLNO	48.70	-	-	0.06
2025-11-12	SLNO	47.72	-	-	0.06
2025-11-13	SLNO	47.29	-	-	0.18
2025-11-14	SLNO	49.40	-	-	0.18
2025-11-17	SLNO	47.28	-	-	0.18
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	SLNO	-0.06	14.63	18.75
2025-10-21	SLNO	-0.06	14.63	18.75
2025-10-22	SLNO	-0.06	14.63	18.75
2025-10-23	SLNO	-0.06	14.63	18.75
2025-10-24	SLNO	-0.06	14.63	18.75
2025-10-27	SLNO	-0.06	15.01	18.33
2025-10-28	SLNO	-0.06	15.01	18.33
2025-10-29	SLNO	-0.06	15.01	18.33
2025-10-30	SLNO	-0.06	15.01	18.33
2025-10-31	SLNO	-0.06	15.01	18.33
2025-11-03	SLNO	-0.06	16.01	18.33
2025-11-04	SLNO	-0.06	16.01	18.33
2025-11-05	SLNO	-0.06	16.01	18.33
2025-11-06	SLNO	-0.06	16.01	18.33
2025-11-07	SLNO	-0.06	16.01	18.14
2025-11-10	SLNO	-0.06	14.77	18.14
2025-11-11	SLNO	-0.06	14.77	18.14
2025-11-12	SLNO	-0.06	14.77	18.25
2025-11-13	SLNO	-0.06	14.77	18.25
2025-11-14	SLNO	-0.06	14.77	17.91
2025-11-17	SLNO	-0.06	11.55	17.91
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.47

Avg. EPS Est. Current Quarter

0.58

Avg. EPS Est. Next Quarter

0.6

Insider Transactions

-0.06

Institutional Transactions

11.55

Beta

-3.08

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

47.7

Max Drawdown 5-Year %

-98.2

Target Price

116.75

P/E

Forward P/E

12.04

PEG

P/S

25.72

P/B

5.13

P/Free Cash Flow

EPS

-1.84

Average EPS Est. Cur. Y

0.18

EPS Next Y. (Est.)

3.63

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-79.5

Relative Volume

1.14

Return on Equity vs Sector %

-42.8

Return on Equity vs Industry %

-27.9

EPS 1 7Days Diff

0.8

EPS 1 30Days Diff

0.86

EBIT Estimation

Soleno Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 152

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.

stock quote shares SLNO – Soleno Therapeutics Inc Stock Price stock today

news today SLNO – Soleno Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch SLNO – Soleno Therapeutics Inc yahoo finance google finance

stock history SLNO – Soleno Therapeutics Inc invest stock market

stock prices SLNO premarket after hours

ticker SLNO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: SLNO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y